IDEAS home Printed from https://ideas.repec.org/a/eee/ehbiol/v59y2025ics1570677x2500067x.html

The impact of biomedical innovation on cancer mortality in 37 countries, 2003–2017

Author

Listed:
  • Lichtenberg, Frank R.

Abstract

Previous studies have shown that biomedical innovation, as measured by the long-run change in the vintage of MeSH descriptors of PubMed articles, has been the principal cause of declining cancer mortality in the U.S. The effect of biomedical innovation on cancer mortality outside of the U.S. may be different from its effect in the U.S. This study uses similar methods to investigate econometrically the impact that biomedical innovation had on cancer mortality in 37 countries during the period 2003–2017. Estimates based on pooled data by cancer site, country, and year indicate that the age-adjusted cancer mortality rate is significantly inversely related to the vintage of descriptors of PubMed articles about that cancer site 9–20 years (but not 0–8 years) earlier, controlling for the age-adjusted cancer incidence rate. The mortality rate is most strongly inversely related to the vintage of descriptors 16 years earlier. This finding is consistent with evidence from other studies that there is a substantial lag from biomedical innovation to population health. Excluding the U.S. (which accounts for 26 % of the cancer deaths in the 37 countries) from the sample does not have a substantial effect on the estimates. 85 % of the 2003–2017 decline in the cancer mortality rate is estimated to be attributable to the 1987–2001 increase in mean vintage. Only 6 % of the 2003–2017 decline in the cancer mortality rate is estimated to be attributable to the contemporaneous decline in the cancer incidence rate. In addition to estimating models using pooled data for many countries, we estimate models of the cancer mortality rate separately for each country. The estimate of the coefficient of vintage 16 years earlier is negative and significant for 24 of the 37 countries, and negative and marginally significant for 2 other countries; it is not positive and significant for any country. The population-weighted mean of the 37 estimates is very similar to the estimate from the model based on pooled data from many countries.

Suggested Citation

  • Lichtenberg, Frank R., 2025. "The impact of biomedical innovation on cancer mortality in 37 countries, 2003–2017," Economics & Human Biology, Elsevier, vol. 59(C).
    • Handle: RePEc:eee:ehbiol:v:59:y:2025:i:c:s1570677x2500067x
    DOI: 10.1016/j.ehb.2025.101534
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S1570677X2500067X
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.ehb.2025.101534?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to

    for a different version of it.

    References listed on IDEAS

    as
    1. Frank R. Lichtenberg, 2019. "The long-run impact of new medical ideas on cancer survival and mortality," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 28(7), pages 722-740, October.
    2. Frank R. LICHTENBERG, 2018. "The Impact of New Drug Launch on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries," JODE - Journal of Demographic Economics, Cambridge University Press, vol. 84(3), pages 309-354, September.
    3. Jonathan Grant & Liz Green & Barbara Mason, 2003. "Basic research and health: a reassessment of the scientific basis for the support of biomedical science," Research Evaluation, Oxford University Press, vol. 12(3), pages 217-224, December.
    4. Jovanovic, Boyan & Yatsenko, Yuri, 2012. "Investment in vintage capital," Journal of Economic Theory, Elsevier, vol. 147(2), pages 551-569.
    5. Jonathan D. Bohlmann & Peter N. Golder & Debanjan Mitra, 2002. "Deconstructing the Pioneer's Advantage: Examining Vintage Effects and Consumer Valuations of Quality and Variety," Management Science, INFORMS, vol. 48(9), pages 1175-1195, September.
    6. repec:bla:scandj:v:94:y:1992:i:0:p:s75-87 is not listed on IDEAS
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jeon, Sung-Hee & Pohl, R. Vincent, 2019. "Medical innovation, education, and labor market outcomes of cancer patients," Journal of Health Economics, Elsevier, vol. 68(C).
    2. Katharina E. Blankart & Frank R. Lichtenberg, 2020. "Are patients more adherent to newer drugs?," Health Care Management Science, Springer, vol. 23(4), pages 605-618, December.
    3. Rebecca McKibbin & Bruce A. Weinberg, 2021. "Does Research Save Lives? The Local Spillovers of Biomedical Research on Mortality," NBER Working Papers 29420, National Bureau of Economic Research, Inc.
    4. Katharina E. Blankart & Frank R. Lichtenberg, 2022. "The Effects of Off-label Drug Use on Disability and Medical Expenditure," NBER Working Papers 30440, National Bureau of Economic Research, Inc.
    5. d’Albis, Hippolyte & Augeraud-Véron, Emmanuelle & Hupkes, Hermen Jan, 2014. "Multiple solutions in systems of functional differential equations," Journal of Mathematical Economics, Elsevier, vol. 52(C), pages 50-56.
    6. Fay, Scott & Mitra, Deb & Wang, Qiong, 2009. "Ask or infer? Strategic implications of alternative learning approaches in customization," International Journal of Research in Marketing, Elsevier, vol. 26(2), pages 136-152.
    7. Nadia Nguyen & Benjamin Lane & Sangwon Lee & Sharon Lipsky Gorman & Yumeng Wu & Alicia Li & Helen Lu & Noemie Elhadad & Michael Yin & Kathrine Meyers, 2022. "A mixed methods study evaluating acceptability of a daily COVID-19 testing regimen with a mobile-app connected, at-home, rapid antigen test: Implications for current and future pandemics," PLOS ONE, Public Library of Science, vol. 17(8), pages 1-19, August.
    8. Kredler, Matthias, 2014. "Vintage human capital and learning curves," Journal of Economic Dynamics and Control, Elsevier, vol. 40(C), pages 154-178.
    9. Volha Lazuka, 2022. "Household and individual economic outcomes of different health shocks: The role of medical innovations," Papers 2206.03306, arXiv.org, revised Feb 2026.
    10. Frank R. Lichtenberg, 2018. "The Impact of Public and Private Research on Premature Cancer Mortality and Hospitalization in the United States, 1999-2013," The American Economist, Sage Publications, vol. 63(2), pages 147-165, October.
    11. Claus Zippel & Sabine Bohnet-Joschko, 2021. "Rise of Clinical Studies in the Field of Machine Learning: A Review of Data Registered in ClinicalTrials.gov," IJERPH, MDPI, vol. 18(10), pages 1-14, May.
    12. Francisco J. Santos-Arteaga & Debora Di Caprio & Madjid Tavana & Aidan O'Connor, 2017. "Formalising The Demand For Technological Innovations: Rational Herds, Market Frictions And Network Effects," International Journal of Innovation Management (ijim), World Scientific Publishing Co. Pte. Ltd., vol. 21(02), pages 1-43, February.
    13. Yatsenko, Yuri & Hritonenko, Natali, 2020. "Optimal asset replacement: Profit maximization under varying technology," International Journal of Production Economics, Elsevier, vol. 228(C).
    14. Guo, Shu & Choi, Tsan-Ming & Chung, Sai-Ho, 2022. "Self-design fun: Should 3D printing be employed in mass customization operations?," European Journal of Operational Research, Elsevier, vol. 299(3), pages 883-897.
    15. Frank R. LICHTENBERG, 2018. "The Impact of New Drug Launch on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries," JODE - Journal of Demographic Economics, Cambridge University Press, vol. 84(3), pages 309-354, September.
    16. Adão, Bernardino & Narajabad, Borghan & Temzelides, Ted, 2024. "Renewable technology adoption costs and economic growth," Energy Economics, Elsevier, vol. 129(C).
    17. Shikhar Sarin & Subin Im & Anthony Di Benedetto & Trina Sego & Ravindra Chitturi, 2025. "Contingent influences of innovation characteristics and firm capabilities on early-mover advantage: A conceptual framework for high-tech environments," AMS Review, Springer;Academy of Marketing Science, vol. 15(3), pages 579-593, December.
    18. Xu, Jiangchuan & Wang, En-Ze, 2024. "The path to energy savings and CO2 emission reductions in China's industrial sector from the perspective of factor price distortions correction - Based on an extended capital vintage model," Energy, Elsevier, vol. 313(C).
    19. Zhu, Yanyuan & Feng, Xiao, 2014. "China's national production function since 1997: A reinvestigation," Working Papers in Economics 2014,2, Bundeswehr University Munich, Economic Research Group.
    20. Gianvito Lanzolla & Alessandro Giudici, 2017. "Pioneering strategies in the digital world. Insights from the Axel Springer case," Business History, Taylor & Francis Journals, vol. 59(5), pages 744-777, July.

    More about this item

    Keywords

    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:ehbiol:v:59:y:2025:i:c:s1570677x2500067x. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/locate/inca/622964 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.